- Home
- ATON vs TOVX Comparison
ATON vs TOVX Comparison
Compare ATON & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATON | TOVX |
|---|---|---|
| Founded | 1973 | 2001 |
| Country | British Virgin Islands | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8M | 7.2M |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | ATON | TOVX |
|---|---|---|
| Price | $0.52 | $0.19 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.7M | 2.1M |
| Earning Date | 02-27-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $0.17 |
| 52 Week High | $15.82 | $1.75 |
Technical Indicators
Market Signals| Indicator | ATON | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 45.73 |
| Support Level | $0.46 | $0.18 |
| Resistance Level | $0.59 | $0.21 |
| Average True Range (ATR) | 0.06 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 9.62 | 33.14 |
Price Performance
Historical ComparisonAbout ATON AlphaTON Capital Corp.
AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.